EDGAR·FLOW

ADARx Pharmaceuticals, Inc. — Form 4

Filed September 29, 2026 · analyzed by the Insider Agent
4 ▲ Likely positive significance 78/100
What the filing says
Director George Simeon (ADRX) bought 9.9M shares (~$27.2M) on the open market (94% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating

Open-market insider purchase — historically a bullish signal.

Tradability signal
NO TRADE

No trade: positive news with only +0.1% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.36% over 4 hrs, n=132). (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
at our read · unknown
$20.65
+10 min · unknown
$20.65 ▲ 0.00%
+30 min · unknown
$20.38 ▼ 1.33%
+1 hr · unknown
$21.20 ▲ 2.66%
+4 hrs · unknown
$20.98 ▲ 1.57%

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ ADRX · stock on Yahoo Finance ↗

See more from September 29, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.